Form 4 Tracker
Anika Therapeutics, Inc.
ANIK

7 insider filings · Latest: Mar 14, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2026Mar 17 11:47 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
6,4496,448(D)

View →

Mar 14, 2026Mar 17 11:47 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
9,38818,777(D)

View →

Mar 15, 2026Mar 17 11:42 PMCheryl R BlanchardDirector
Option Exercise
25,13125,132(D)

View →

Mar 14, 2026Mar 17 11:42 PMCheryl R BlanchardDirector
Option Exercise
24,51949,040(D)

View →

Mar 15, 2026Mar 17 11:39 PMIan McleodSVP, CAO & Treasurer
Option Exercise
2,6582,659(D)

View →

Mar 14, 2026Mar 17 11:39 PMIan McleodSVP, CAO & Treasurer
Option Exercise
3,7747,550(D)

View →

Mar 9, 2026Mar 11 8:25 PMDavid ColleranEVP, General Counsel, Corp Sec
Option Exercise
5,4650(D)

View →

Mar 9, 2026Mar 11 8:24 PMCheryl R BlanchardDirector
Option Exercise
20,0010(D)

View →

Mar 9, 2026Mar 11 8:24 PMIan McleodSVP, CAO & Treasurer
Option Exercise
2,1970(D)

View →

Mar 14, 2026Stephen D. GriffinDirector, President and CEO
Option Exercise
12,82425,649(D)

View →